Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)

v3.24.0.1
Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) - Stock Appreciation Rights (SARs) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Shares    
Beginning balance outstanding, shares (in shares) 147,000  
Granted, shares (in shares) 18,000  
Exercised, shares (in shares) 0  
Forfeited, shares (in shares) (4,000)  
Expired, shares (in shares) (49,000)  
Ending balance outstanding, shares (in shares) 112,000 147,000
Exercisable, shares (in shares) 65,000  
Weighted-average exercise price    
Weighted average exercise price, outstanding (in dollars per share) $ 63.88 $ 82.16
Granted, weighted-average exercise price (in dollars per share) 58.79  
Exercised, weighted-average exercise price (in dollars per share) 0  
Forfeited, weighted-average exercise price (in dollars per share) 81.59  
Expired, weighted-average exercise price (in dollars per share) 115.45  
Exercisable, weighted-average exercise price (in dollars per share) $ 64.84  
Weighted-average remaining contractual term    
Weighted-average remaining contractual term, outstanding (years) 1 year 2 months 12 days 1 year 3 months 18 days
Exercisable, weighted-average remaining contractual term (years) 8 months 12 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding $ 0 $ 0
Exercisable, aggregate intrinsic value $ 0